###BASE_URL###
2014-06-26 | permalink
Monsanto said its earnings fell more than 5 percent in the third fiscal quarter on lower sales of biotech seeds, but its performance still topped Wall Street estimates and the company raised its 2014 outlook. It also announced plans to repurchase $10 billion in shares.
2014-06-26 | permalink
Monsanto said its earnings fell more than 5 percent in the third fiscal quarter on lower sales of biotech seeds, but its performance still topped Wall Street estimates and the company raised its 2014 outlook. It also announced plans to repurchase $10 billion in shares.
GENET-news is providing a daily news service on a range of topics regarding genetic engineering. We are screening the worldwide English news, press releases and other publications to provide you with a strategic selection of information. GENET-news enables you to stay informed about all aspects of the global controversy around GE technologies and GE organisms. You can subscribe by email.
The GENET-forum list provides you with additional background information and more voluminous reports. It is only open for GENET members. Please contact the coordinator for membership and subscription.